These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17183161)

  • 1. Effects of the magnesium and chloride ions and shikimate on the structure of shikimate kinase from Mycobacterium tuberculosis.
    Dias MV; Faím LM; Vasconcelos IB; de Oliveira JS; Basso LA; Santos DS; de Azevedo WF
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2007 Jan; 63(Pt 1):1-6. PubMed ID: 17183161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of shikimate kinase from Mycobacterium tuberculosis reveals the binding of shikimic acid.
    Pereira JH; de Oliveira JS; Canduri F; Dias MV; Palma MS; Basso LA; Santos DS; de Azevedo WF
    Acta Crystallogr D Biol Crystallogr; 2004 Dec; 60(Pt 12 Pt 2):2310-9. PubMed ID: 15583379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of Mycobacterium tuberculosis shikimate kinase in complex with shikimic acid and an ATP analogue.
    Gan J; Gu Y; Li Y; Yan H; Ji X
    Biochemistry; 2006 Jul; 45(28):8539-45. PubMed ID: 16834327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of shikimic acid with shikimate kinase.
    Pereira JH; de Oliveira JS; Canduri F; Dias MV; Palma MS; Basso LA; de Azevedo WF; Santos DS
    Biochem Biophys Res Commun; 2004 Dec; 325(1):10-7. PubMed ID: 15522194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of shikimate kinase from Mycobacterium tuberculosis reveals the dynamic role of the LID domain in catalysis.
    Gu Y; Reshetnikova L; Li Y; Wu Y; Yan H; Singh S; Ji X
    J Mol Biol; 2002 Jun; 319(3):779-89. PubMed ID: 12054870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystallographic studies of shikimate binding and induced conformational changes in Mycobacterium tuberculosis shikimate kinase.
    Dhaliwal B; Nichols CE; Ren J; Lockyer M; Charles I; Hawkins AR; Stammers DK
    FEBS Lett; 2004 Sep; 574(1-3):49-54. PubMed ID: 15358538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycobacterium tuberculosis shikimate kinase inhibitors: design and simulation studies of the catalytic turnover.
    Blanco B; Prado V; Lence E; Otero JM; Garcia-Doval C; van Raaij MJ; Llamas-Saiz AL; Lamb H; Hawkins AR; González-Bello C
    J Am Chem Soc; 2013 Aug; 135(33):12366-76. PubMed ID: 23889343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of phosphoryl transfer catalyzed by shikimate kinase from Mycobacterium tuberculosis.
    Hartmann MD; Bourenkov GP; Oberschall A; Strizhov N; Bartunik HD
    J Mol Biol; 2006 Dec; 364(3):411-23. PubMed ID: 17020768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mode of action of recombinant Mycobacterium tuberculosis shikimate kinase: kinetics and thermodynamics analyses.
    Rosado LA; Vasconcelos IB; Palma MS; Frappier V; Najmanovich RJ; Santos DS; Basso LA
    PLoS One; 2013; 8(5):e61918. PubMed ID: 23671579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shikimate kinase (EC 2.7.1.71) from Mycobacterium tuberculosis: kinetics and structural dynamics of a potential molecular target for drug development.
    Saidemberg DM; Passarelli AW; Rodrigues AV; Basso LA; Santos DS; Palma MS
    Curr Med Chem; 2011; 18(9):1299-310. PubMed ID: 21366533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structures of Helicobacter pylori shikimate kinase reveal a selective inhibitor-induced-fit mechanism.
    Cheng WC; Chen YF; Wang HJ; Hsu KC; Lin SC; Chen TJ; Yang JM; Wang WC
    PLoS One; 2012; 7(3):e33481. PubMed ID: 22438938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular model of shikimate kinase from Mycobacterium tuberculosis.
    Filgueira de Azevedo W; Canduri F; Simões de Oliveira J; Basso LA; Palma MS; Pereira JH; Santos DS
    Biochem Biophys Res Commun; 2002 Jul; 295(1):142-8. PubMed ID: 12083781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of shikimate kinase, an in vivo essential metabolic enzyme in the nosocomial pathogen Acinetobacter baumannii, in complex with shikimate.
    Sutton KA; Breen J; MacDonald U; Beanan JM; Olson R; Russo TA; Schultz LW; Umland TC
    Acta Crystallogr D Biol Crystallogr; 2015 Aug; 71(Pt 8):1736-44. PubMed ID: 26249354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of mechanism and chemical inhibitors of shikimate kinase.
    Chagaleti BK; Reddy MBR; Saravanan V; B S; D P; Senthil Kumar P; Kathiravan MK
    J Biomol Struct Dyn; 2023; 41(23):14582-14598. PubMed ID: 36974959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shikimate kinase, a protein target for drug design.
    Coracini JD; de Azevedo WF
    Curr Med Chem; 2014; 21(5):592-604. PubMed ID: 24164195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the Catalytic Mechanism and the Nature of the Transition State of an Attractive Drug-Target Enzyme (Shikimate Kinase) by Quantum Mechanical/Molecular Mechanical (QM/MM) Studies.
    Yao J; Wang X; Luo H; Gu P
    Chemistry; 2017 Nov; 23(64):16380-16387. PubMed ID: 28925075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of salts on the function and conformational stability of shikimate kinase.
    Cerasoli E; Kelly SM; Coggins JR; Lapthorn AJ; Clarke DT; Price NC
    Biochim Biophys Acta; 2003 May; 1648(1-2):43-54. PubMed ID: 12758146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzothiazole Derivative as a Novel Mycobacterium tuberculosis Shikimate Kinase Inhibitor: Identification and Elucidation of Its Allosteric Mode of Inhibition.
    Mehra R; Rajput VS; Gupta M; Chib R; Kumar A; Wazir P; Khan IA; Nargotra A
    J Chem Inf Model; 2016 May; 56(5):930-40. PubMed ID: 27149193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of shikimate kinase inhibitors among anti-Mycobacterium tuberculosis compounds by LC-MS.
    Simithy J; Reeve N; Hobrath JV; Reynolds RC; Calderón AI
    Tuberculosis (Edinb); 2014 Mar; 94(2):152-8. PubMed ID: 24429106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an ESI-LC-MS-based assay for kinetic evaluation of Mycobacterium tuberculosis shikimate kinase activity and inhibition.
    Simithy J; Gill G; Wang Y; Goodwin DC; Calderón AI
    Anal Chem; 2015 Feb; 87(4):2129-36. PubMed ID: 25629762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.